Home

NexGel, Inc - Common Stock (NXGL)

2.6300
+0.0600 (2.33%)
NASDAQ · Last Trade: Apr 8th, 3:20 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to NexGel, Inc - Common Stock (NXGL)

3M Company MMM +1.29%

3M Company offers a range of advanced adhesive and medical products that directly compete with NexGel’s hydrogel technologies. Both companies target healthcare providers and patients requiring effective wound care and pain management solutions. 3M leverages its extensive research and development capabilities, a broad product portfolio, and established distribution channels, which gives it a significant edge in market reach and innovation, challenging NexGel’s market share.

Acelity Inc.

Acelity specializes in wound care products that utilize advanced materials similar to those developed by NexGel. The company’s focus on biologics and regenerative medicine allows it to develop innovative solutions for complicated wound care that can outperform traditional hydrogel alternatives. Acelity's strong presence in the surgical market segments and established reputation among healthcare professionals provide it with a competitive advantage over NexGel.

ConvaTec Group PLC

ConvaTec competes with NexGel in the medical device and wound care sectors by offering a diverse range of advanced hydrocolloid and hydrogel products for effective wound management. With a well-established global distribution network and a strong brand reputation in chronic wound healing, ConvaTec could leverage its scale and resources to maintain a competitive edge over NexGel, particularly in markets requiring high-quality, reliable wound care solutions.

Integra LifeSciences Holdings Corporation IART +0.05%

Integra LifeSciences focuses on regenerative technologies, including products that serve similar applications as NexGel's offerings. Their robust emphasis on innovation in nerve regeneration and advanced wound care products allows them to capture segments of the market that require specialized care. While NexGel aims for niche product applications, Integra’s broader market approach may afford it a competitive advantage in penetrating more segments effectively.

Smith & Nephew plc

Smith & Nephew is a major player in the global wound care market, focusing on advanced wound management solutions that include hydrogel and other innovative products. Their comprehensive product offerings and strong focus on research and development allow them to address a wide array of patient needs efficiently. Given their established market presence and broader product base, Smith & Nephew has a competitive advantage over NexGel in terms of brand trust and resource allocation.